本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Redhill Biopharma Ltd

0.5800
+0.00490.85%
成交量:8.28萬
成交額:4.73萬
市值:352.69萬
市盈率:-4.27
高:0.5801
開:0.5700
低:0.5600
收:0.5751
52周最高:2.79
52周最低:0.5600
股本:608.09萬
流通股本:501.95萬
量比:2.38
換手率:1.65%
股息:- -
股息率:- -
每股收益(TTM):-0.1358
每股收益(LYR):-0.1358
淨資產收益率:-1708.61%
總資產收益率:-22.79%
市淨率:0.83
市盈率(LYR):-4.27

資料載入中...

2019/05/15

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]